Effect of GP IIb/IIIa inhibitor duration on the clinical prognosis of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction with no-/slow-reflow phenomenon.
Xiangming Hu,Weimian Wang,Jingguang Ye,Yan Lin,Bingyan Yu,Langping Zhou,Yingling Zhou,Haojian Dong +7 more
Reads0
Chats0
TLDR
In this paper, the authors compared the efficacy and safety of short and long-term GP IIb/IIIa infusion in STEMI patients with the no/slow-reflow phenomenon.About:
This article is published in Biomedicine & Pharmacotherapy.The article was published on 2021-09-21 and is currently open access. It has received 2 citations till now. The article focuses on the topics: Percutaneous coronary intervention & Mace.read more
Citations
More filters
Journal ArticleDOI
Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials
TL;DR: In this paper , the authors compared IC and IV tirofiban in patients with ST-segment elevation myocardial infarction (STEMI) and receiving primary percutaneous coronary interventions (PPCI).
References
More filters
Journal ArticleDOI
[2018 ESC/EACTS Guidelines on myocardial revascularization].
Franz-Josef Neumann,Miguel Sousa-Uva,Anders Ahlsson,Fernando Alfonso,Adrian P. Banning,Umberto Benedetto,Robert A. Byrne,Jean-Philippe Collet,Volkmar Falk,Stuart J. Head,Peter Jüni,Adnan Kastrati,Akos Koller,Steen Dalby Kristensen,Josef Niebauer,Dimitrios J. Richter,Petar M. Seferović,Dirk Sibbing,Giulio G. Stefanini,Stephan Windecker,Rashmi Yadav,Michael O. Zembala +21 more
Journal ArticleDOI
Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.
Johan H. C. Reiber,Patrick W. Serruys,C. J. Kooijman,William Wijns,C. J. Slager,Jan J. Gerbrands,Johan C.H. Schuurbiers,A. den Boer,P. G. Hugenholtz +8 more
TL;DR: It is concluded that the biological variations are a source of major concern and that further attempts toward standardization of the angiographic procedure are seriously needed.
Journal ArticleDOI
Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death
TL;DR: Increased LV mass and hypertrophy are associated with increased risk for sudden death after accounting for known risk factors.
Journal ArticleDOI
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions.
Patrick T. O'Gara,Frederick G. Kushner,Deborah D. Ascheim,Donald E. Casey,Mina K. Chung,James A. de Lemos,Steven M. Ettinger,James C. Fang,Francis M. Fesmire,Barry A. Franklin,Christopher B. Granger,Harlan M. Krumholz,Jane A. Linderbaum,David A. Morrow,L. Kristin Newby,Joseph P. Ornato,Narith N. Ou,Martha J. Radford,Jacqueline E. Tamis-Holland,Carl L. Tommaso,Cynthia M. Tracy,Y. Joseph Woo,David Zhao +22 more
TL;DR: WRITING COMMITTEE MEMBERS* Patrick T. O’Gara, MD, FACC, FAHA, Chair†; Frederick G. Kushner,MD, F ACC,FAHA, FSCAI, Vice Chair*†; Deborah D. Kushner-Kushner, PhD, MBA, FACP, FAha‡; Mina K. Linderbaum, MS, CNP-BC.
Journal ArticleDOI
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial
Hirotoshi Watanabe,Takenori Domei,Takeshi Morimoto,Masahiro Natsuaki,Hiroki Shiomi,Toshiaki Toyota,Masanobu Ohya,Satoru Suwa,Kensuke Takagi,Mamoru Nanasato,Yoshiki Hata,Masahiro Yagi,Nobuhiro Suematsu,Takafumi Yokomatsu,Itaru Takamisawa,Masayuki Doi,Toshiyuki Noda,Hideki Okayama,Yoshitane Seino,Tomohisa Tada,Hiroki Sakamoto,Kiyoshi Hibi,Mitsuru Abe,Kazuya Kawai,Koichi Nakao,Kenji Ando,Kengo Tanabe,Yuji Ikari,Keiichi Igarashi Hanaoka,Yoshihiro Morino,Ken Kozuma,Kazushige Kadota,Yutaka Furukawa,Yoshihisa Nakagawa,Takeshi Kimura +34 more
TL;DR: It is suggested that a shorter duration of DAPT may provide benefit, although given study limitations, additional research is needed in other populations.